12 September 2018
The ePOC handheld blood analysis system has recently received FDA clearance for an expanded testing compendium, including Blood Urea Nitrogen, and Total Cardon Dioxide. Peter Koerte, President, POC Division, Siemens Healthineers, discusses how this recent innovation is set to improve care for critically ill patients with renal injury and metabolic diseases, as well as how the information management system, POCcelerater, can enhance POC device connectivity.